Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma

Abstract

All differentially expressed proteins are candidate biomarkers for DS, providing opportunities for the development of non-invasive prenatal diagnosis. As these are preliminary findings, follow-up experiments are needed for their evaluation.